Literature DB >> 18491097

Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma.

Redina Ljumanovic1, Johannes A Langendijk, Otto S Hoekstra, Dirk L Knol, C René Leemans, Jonas A Castelijns.   

Abstract

The purpose was to determine if pre-radiotherapy (RT) and/or post-radiotherapy magnetic resonance (MR) imaging can predict response in patients with laryngeal carcinoma treated with RT. Pre- and post-RT MR examinations of 80 patients were retrospectively reviewed and associated with regard to local control. Pre-RT MR imaging parameters such as tumor involvement of specific laryngeal anatomic subsites including laryngeal cartilages and post-RT changes, i.e., complete resolution of the tumor or focal mass/asymmetric obliteration of laryngeal tissue and signal pattern on T2-weighted images, were evaluated. Local control was defined as absence of a recurrence at the primary site for 2 years. Local control rates based on pretreatment MR findings were 73% for low pre-RT risk-profile and 29% for high pre-RT risk-profile patients (p=0.0001). Based on posttreatment MR findings, local control rates were 100% score 1, 64% score 2, and 4% score 3 (p<0.0001). Using post-RT T2-weighted images, significant association was found between differences in signal pattern and local control: 77% hypointense, 54% isointense and 15% hyperintense lesions (p<0.001). Differences between means of delay of post-MRI examination were significantly associated with regard to local control (p=0.003); recurrent tumors followed 5 months after RT were more easily detectable on MRI than recurrent tumors within 4 months after RT. Sensitivity, specificity, accuracy, negative and positive predictive values of post-RT score 3 were 96%, 76%, 83%, 98% and 66%. Pre- and post-RT MRI evaluation of the larynx can identify patients at high risk for developing local failure.

Entities:  

Mesh:

Year:  2008        PMID: 18491097     DOI: 10.1007/s00330-008-0986-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  Irradiated carcinoma of the tongue: correlation of MR imaging findings with pathology.

Authors:  Noriaki Tomura; Osamu Watanabe; Koki Kato; Satoshi Takahashi; Jiro Watarai; Masato Sageshima; Michinori Yokomizo
Journal:  AJR Am J Roentgenol       Date:  2002-03       Impact factor: 3.959

2.  Magnetic resonance imaging of extracranial head and neck tumours.

Authors:  J Kabala; P Goddard; P Cook
Journal:  Br J Radiol       Date:  1992-05       Impact factor: 3.039

3.  Variability of tumor volumes in T3-staged head and neck tumors.

Authors:  F A Pameijer; A J Balm; F J Hilgers; S H Muller
Journal:  Head Neck       Date:  1997-01       Impact factor: 3.147

4.  [Evaluation of therapeutic effect using enhanced MRI in lung cancer: evaluation of methods in terms of necrosis].

Authors:  Y Ohno; M Kusumoto; M Kono
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1997-10

5.  Radiologic appearance of the irradiated larynx. Part I. Expected changes.

Authors:  S K Mukherji; A A Mancuso; I M Kotzur; W M Mendenhall; P S Kubilis; R P Tart; W R Lee; D Freeman
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

6.  Pre- and post-radiotherapy computed tomography in laryngeal cancer: imaging-based prediction of local failure.

Authors:  F A Pameijer; R Hermans; A A Mancuso; W M Mendenhall; J T Parsons; S P Stringer; P S Kubilis; H van Tinteren
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

7.  Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma.

Authors:  J R Kraas; T E Underhill; R B D'Agostino; D W Williams; J A Cox; K M Greven
Journal:  Head Neck       Date:  2001-12       Impact factor: 3.147

8.  Radiologic appearance of the irradiated larynx. Part II. Primary site response.

Authors:  S K Mukherji; A A Mancuso; I M Kotzur; W M Mendenhall; P S Kubilis; R P Tart; D Freeman; W R Lee
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

9.  Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.

Authors:  K M Greven; D W Williams; J W Keyes; W F McGuirt; N E Watson; M E Randall; M Raben; K R Geisinger; J O Cappellari
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

10.  MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis.

Authors:  Q Y Gong; G L Zheng; H Y Zhu
Journal:  Comput Med Imaging Graph       Date:  1991 Nov-Dec       Impact factor: 4.790

View more
  6 in total

1.  Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?

Authors:  Peter Zbären; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-21       Impact factor: 2.503

2.  Does primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site outcome?

Authors:  K S S Bhatia; A D King; K-H Yu; A C Vlantis; G Mk Tse; F Kf Mo; A T Ahuja
Journal:  Br J Radiol       Date:  2010-11       Impact factor: 3.039

3.  T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma.

Authors:  A D King; C K Keung; K-H Yu; F K F Mo; K S Bhatia; D K W Yeung; G M K Tse; A C Vlantis; A T Ahuja
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-10       Impact factor: 3.825

Review 4.  Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis.

Authors:  Anouk van der Hoorn; Peter Jan van Laar; Gea A Holtman; Henriette E Westerlaan
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

Review 5.  Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI.

Authors:  Minerva Becker; Habib Zaidi
Journal:  Br J Radiol       Date:  2014-02-03       Impact factor: 3.039

6.  MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?

Authors:  S E J Connor; C Burd; N Sivarasan; V Goh
Journal:  Eur Radiol       Date:  2021-05-19       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.